在结肠癌中探索NK细胞动态和CD47-SIRPα轴
Latif Yilmaz1, Serdar Oztuzcu2, Omer Eronat3
1Department of General Surgery Faculty of Medicine Gaziantep University Gaziantep Turkey.
Human immunology
|February 11, 2025
概括
SIRPα/CD47免疫检查点轴对结肠癌产生影响. 手术后,NK细胞数量下降,而NK细胞上的SIRPα水平下降,这表明在结直肠癌免疫治疗中具有复杂的作用.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 癌症免疫疗法癌症免疫疗法
背景情况:
- SIRPα/CD47轴是一个关键的免疫检查点,抑制巨细胞的自我细胞的细胞化.
- 针对这一轴为癌症免疫疗法提供了潜力,特别是在结直肠癌中.
- 了解NK细胞动态和CD47/SIRPα相互作用对于开发有效的治疗方法至关重要.
研究的目的:
- 为了研究结肠癌患者手术后的NK细胞动态.
- 评估CD47/SIRPα轴对结直肠癌NK细胞的影响.
- 评估与NK细胞活性和瘤特征相关的SIRPα和CD47表达的变化.
主要方法:
- 对结肠癌患者NK细胞数量和干扰素- (IFNγ) 水平的分析.
- 在瘤组织中评估CD47免疫活性.
- 在外科手术后对NK细胞 (CD16+/56+和CD3-) 的SIRPα表达量的量化.
主要成果:
- 在手术后观察到NK细胞数量的显著,时间依赖的减少.
- 患者的IFNγ水平低于健康对照组,并且在手术后没有变化.
- 瘤显示CD47表达低,NK细胞的术后SIRPα水平在患者中显著降低,无论CD47状态如何.
结论:
- CD47/SIRPα轴在结直肠癌中起着复杂的作用.
- 手术后NK细胞数量下降,表明潜在的免疫抑制.
- 需要对更大的队列进行进一步的研究,以确认这些发现及其治疗含义.
相关概念视频
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.2K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K
Role Of Notch Signalling In Intestinal Stem Cell Renewal
2.0K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.0K
Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
Renewal of Intestinal Stem Cells
2.5K
The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the...
2.5K
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K


